» Articles » PMID: 11282212

Effectiveness of a Single Dose of Acellular Pertussis Vaccine to Prevent Pertussis in Children Primed with Pertussis Whole Cell Vaccine

Overview
Journal Vaccine
Date 2001 Apr 3
PMID 11282212
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We estimated the protection given by one booster dose of acellular pertussis vaccine (aP) given at 18 months or before school entry to children already primed with whole cell vaccine (wP). Case-control studies were conducted in these two age groups. In children who received or were eligible to receive their 18 months booster, the risk of pertussis was 1.4 and 3.6 times higher for those with 4 and 3 wP, respectively, compared to those with 3 wP + 1 aP. In 5 and 6 yr old children, the risk of pertussis among the subjects with 5 and 4 wP, was 1.4 and 2.1 times higher respectively than in those who received 4 wP + 1 aP. A single dose of aP increased the protection against pertussis and this protection was greater than that obtained with a wP booster.

Citing Articles

Acellular pertussis vaccine efficacy: An updated systematic review and meta -analysis.

Mansour-Ghanaei R, Moradi-Lakeh M, Shakerian S, Karimi A, Esmaeeli S, Shokraneh F Med J Islam Repub Iran. 2017; 30:451.

PMID: 28491826 PMC: 5419227.


Has the change to acellular pertussis vaccine improved or worsened pertussis control?.

Halperin S, De Serres G CMAJ. 2006; 175(10):1227.

PMID: 17098952 PMC: 1626494. DOI: 10.1503/cmaj.060817.


Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.

Vickers D, Ross A, Mainar-Jaime R, Neudorf C, Shah S CMAJ. 2006; 175(10):1213-7.

PMID: 17098950 PMC: 1626510. DOI: 10.1503/cmaj.051637.